Connect with us
[the_ad id="89560"]

Health

UK to ban puberty blockers for minors indefinitely

Published

3 minute read

From LifeSiteNews

By Andreas Wailzer

UK Health Secretary Wes Streeting announced Wednesday that he will indefinitely extend a ban on puberty blockers for minors under the age of 18. The only exception is for clinical trials.

Puberty blockers will be banned indefinitely in the U.K. for under 18-year-olds, except for clinical trials.

In May of this year, the then-government of Rishi Sunak used emergency legislation to temporarily ban puberty blockers for minors. Health Secretary Wes Streeting announced on Wednesday that he will indefinitely extend the ban on the supply and sale of puberty blockers.

The Department of Health cited the Commission on Human Medicines’ (CHM) expert advice that said there was “currently an unacceptable safety risk in the continued prescription of puberty blockers to children.”

The U.K.’s National Health Service (NHS) already halted the prescription of puberty blockers to children in March. In May, the then-Conservative government introduced a ban, preventing the prescription of puberty blockers by European or private prescribers and legally restricting the NHS’s use of the drugs to clinical trials.

The ban was upheld in July by the High Court after pro-LGBT activists brought a challenge to the ruling because they “were concerned for the safety and welfare of young trans people in the UK.”

The prohibition of prescribing harmful puberty blockers for children was prompted by the Cass Review, an extensive report by pediatrician Dr. Hilary Cass that pointed out the significant risks of the medication and the lack of evidence regarding the alleged benefits of puberty blockers.

Health Secretary Streeting said that he would “always put the safety of children first” and added that his approach would “continue to be informed by Dr [Hilary] Cass’s review, which found there was insufficient evidence to show puberty blockers were safe for under-18s.”

Earlier on the same day that the nationwide ban was announced, the Parliament of Northern Ireland had voted unanimously to permanently ban puberty blockers in order to prevent the province from becoming a “back door” for the distribution of the drugs in the U.K.

“This marks a significant step in safeguarding children, preventing Northern Ireland from becoming a ‘back door’ for these unregulated treatments – a concern highlighted by Susie Green’s earlier attempts to circumvent mainland restrictions,” he said.

Susie Green is a transgender activist who set up a clinic in Northern Ireland in an attempt to circumvent the restrictions in mainland Britain.

“However, we must remain vigilant, as the demand for these drugs may drive young people to unregulated, dangerous sources,” Jordan stressed, urging lawmakers to prioritize safeguarding children.

COVID-19

Mel Gibson tells Joe Rogan about alternative cancer treatments, dangers of Remdesivir

Published on

From LifeSiteNews

By Stephen Kokx

In the wide-ranging interview, Mel Gibson told Joe Rogan about his experience with Remdesivir, the pharmaceutical industry and alternative treatments for cancer.

Mel Gibson discussed a wide range of issues with podcaster Joe Rogan this week, almost all of them eliciting strong reactions on social media, especially his comments on cancer and the medical establishment.  

Gibson contracted COVID-19 in April 2020. During a week-long hospital stay, he was administered the dangerous drug Remdesivir, which, despite having been known to have a mortality rate of over 50 percent in trials, was approved by Dr. Anthony Fauci for use in hospitals during the pandemic. 

Gibson told Rogan that the experimental treatment nearly ended his life. 

“[Remdesivir] kills you. I found that afterward. And that’s why I wonder about Fauci,” Gibson said.  

 

Hospitals were incentivized to use Remdesivir, which has been shown to cause kidney failure, after the U.S. government approved a 20 percent reimbursement bonus for its use. Medical facilities also  obtained money from the government for classifying deaths as being due to COVID-19. Critics allege that those policies enticed medical professionals to use the risky treatment in order to kill patients as a way to unethically boost profits. 

Gibson told Rogan that he acquired COVID from his gardener, who he had known for twenty years, but that he did not survive his illness. 

“We both went to the same hospital, and he died, and I didn’t … I think we both got Remdesivir, which is not good,” he explained.  

“I don’t know why Fauci’s still walking around… or at least free,” he further remarked. 

Gibson and Rogan also talked about cancer and Big Pharma. Gibson revealed that he knows people who have been healed from the illness due to alternative treatments.  

“I have three friends. All three of them had stage 4 cancer. All three of whom don’t have cancer right now at all. And they had some serious stuff going on,” Gibson said. 

“And what did they take?” Rogan asked. 

“They took …what you’ve heard they’ve taken,” he replied. 

“Ivermectin, Fenbendazole,” Rogan said. “I’m hearing that a lot.” 

“They drank hydrochloride something or other … people drinking methylene blue,” Gibson said.  

“There’s a lot of stuff that does work, which is very strange,” Rogan remarked. “Because, again, it’s profit, when you hear about things that are demonized and they turn out to be effective, you always wonder: ‘what is going on here?’ How is [sic] our medical institutions, how have they failed us so that things that do cure you are not promoted because they’re not profitable? They can’t control it. They don’t have a patent on it. Whether it’s Vitamin D, K2, Magnesium, Zinc. I do all that stuff.” 

On Friday morning, an X-approved post titled “Mel Gibson’s Cancer Cure Claim Sparks Medical Debate” was published on the trending section. Some users piggybacked on Gibson’s remarks by stating that they too have used or know people who are using treatments similar to the ones Gibson’s friends did and that “cancer research” is a racket. 

 

 

 

Others were unconvinced and re-iterated the media narrative that ivermectin is a simply a “dewormer.”

 

Elsewhere in their conversation, Gibson defended the authenticity of the Shroud of Turin and the historical reality of the resurrection of Christ, a topic Rogan has seemingly taken a heightened interest in recently given that he discussed the matter in depth on his show with a Protestant guest less than two weeks ago.  

Continue Reading

Alberta

Former AHS head, Dr. Chris Eagle will lead Acute Care Alberta

Published on

Refocusing acute care leadership for the future

Alberta’s government is bringing in the expertise and experience needed to continue refocusing the health care system for the benefit of all Albertans.

Alberta’s government is committed to refocusing the health care system so that Albertans can access the health care services they need when and where they need them. The work to transform the system is making significant progress, particularly with the recent launch of Primary Care Alberta in November 2024, and the continued advancement in establishing Alberta’s new acute care provincial health agency.

Acute care, which includes hospitals, emergency services and surgery care, is a significant part of the health care system, providing critical care to Albertans when they need it most. Acute Care Alberta, the new acute care provincial health agency, will work to speed up access to high-quality care, reduce wait times and make sure the patient’s journey through the system is efficient and effective across the province.

As progress is made to establish Acute Care Alberta, Alberta’s government is appointing Dr. Chris Eagle as chair and interim president and CEO. This appointment will take effect Feb. 1 to coincide with the establishment of Acute Care Alberta as a legal entity. Dr. Eagle’s focus will be on preparing the organization for its first day of operations later this spring. His appointment to the position is pending finalization of his contract.

Dr. Eagle has significant experience supporting and leading health care organizations and projects across Alberta, including his time as president and CEO of Alberta Health Services (AHS) from 2010 to 2013. His extensive experience in the health field will allow him to guide the work to operationalize Acute Care Alberta.

To help support Dr. Eagle’s work and to lead AHS through its transition from a regional health authority to a hospital-based service provider, Andre Tremblay, deputy minister of Alberta Health, has been appointed interim president and CEO of AHS.

“Acute care is the most complex part of the health care system, and it’s critical that we have the right leadership in place to see this work through and make positive changes to the health care system for Albertans now and into the future. I want to extend my sincerest gratitude to Athana Mentzelopoulos for the work she has done during her time leading Alberta Health Services.”

Adriana LaGrange, Minister of Health

Tremblay brings a wealth of public service and health care delivery experience to the position. With more than 20 years of public sector leadership, he has served in several senior leadership positions. Prior to joining Health in June 2023, Tremblay has been deputy minister at Education, Agriculture and Forestry, and Transportation. This is also his second leadership role at Alberta Health, having previously served as an associate deputy minister. He was also previously appointed as the deputy clerk of executive council and deputy secretary to cabinet. In his role as interim president and CEO, Tremblay will not receive a salary. His salary as deputy minister will remain the same.

Tremblay will continue as deputy minister through this critical period of transition and change for Alberta’s health care system. He will also oversee the recruitment of a permanent president and CEO for Acute Care Alberta. He is best positioned to continue leading efforts to refocus the health care system while supporting the transition of Alberta Health Services to an acute care service provider.

While in the interim role, Tremblay will work with AHS leadership to oversee operations, support staff transitions to Primary Care Alberta and establish Acute Care Alberta as a legal entity ahead of its operationalization this spring. Throughout this work, Albertans will continue to access acute care services as they always have and there will be no impact to front-line health care workers.

The AHS board of directors will begin the search for a permanent president and CEO immediately, and more details will be provided once the hiring process is complete.

“I am excited to take on this role and support the efforts to refocus Alberta’s health care system and to create an improved acute care system that will make sure Albertans have access to the best health care services they need, no matter where they live in the province.”

Dr. Chris Eagle, chair, and interim president and CEO, Acute Care Alberta

“We are at a critical time in the work that is underway to refocus the health care system. I am confident we can continue to make great strides to achieve the goal of making health care better for everyone in Alberta. I want to thank Athana Mentzelopoulos for her hard work, commitment and leadership during her time in the role.”

Angela Fong, board chair, Alberta Health Services

“We have made great progress refocusing the health care system and I am eager to take on this new role and support the work being done to improve health care across the province. I look forward to leading AHS as it transitions to a service delivery provider and engaging with front-line workers and staff across the system in the coming months.”

Andre Tremblay, interim president and CEO, Alberta Health Services, and deputy minister, Alberta Health
Continue Reading

Trending

X